CoQ10 100 mg

CoQ10 100 mg

Swanson4.8 (8,952 ratings)
Format:Softgel Quantity: 50 Softgel(s) · 50 servings
Goals
$11.79 $0.23 per serving

Product analysis

55 out of 100

CoQ10 100 mg offers focused CoQ10 supplementation at moderate value. Its form is not stated, leaving preparation differences unresolved.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The specific CoQ10 form is not disclosed. That limits a closer comparison of the preparation rather than establishing poor quality.

Ingredient Transparency63

The CoQ10 amount is stated clearly. The missing form detail makes the preparation harder to compare.

Value For Money60

The CoQ10 serving offers moderate value. That conclusion concerns the serving cost and does not establish an advantage for its undisclosed form.

Customer Satisfaction93

Customer ratings are strongly favorable across a large number of buyers. The volume gives a broad picture of satisfaction without establishing effectiveness.

Product Focus68

A single active keeps the CoQ10 purpose clear. Its related health aims remain centered on the same ingredient.

Format
Softgel
Container
50 Softgel(s)
Per serving
$0.23
Customer rating
4.8 · 8,952 ratings
Report analysis

Goals

Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Conventional CoQ10 has limited and mixed evidence for vascular, blood-pressure and lipid changes in selected adult populations. Its declared active serving amount supports the saved contribution without establishing the study’s duration or regimen. A generic CoQ10 declaration does not establish a redox form or a delivery advantage, and these findings do not establish prevention of cardiovascular events.

How this product is rated for Heart Health

Ingredient fit86

Coenzyme Q-10 anchors the relevant saved findings. Its serving amount makes a partial contribution under the saved comparison.
Goal fit
Coenzyme Q-10 gives this formula a focused ingredient connection to heart-health markers, while its links to other goals reduce exclusive focus.
Dose adequacy
Coenzyme Q-10’s declared serving amount partly meets the saved comparison; this does not establish an optimal or clinically effective regimen.

Pathways53

The connection is concentrated in endothelial nitric-oxide function. Other heart-health processes have little or no coverage.
Depth
The strongest saved connection is to endothelial nitric-oxide function; this describes marker-related coverage rather than demonstrated prevention of heart disease.
Breadth
Coverage is concentrated in endothelial nitric-oxide function, with little or no coverage of the other evaluated heart-health processes.

Evidence98

CoQ10 leads the evidence finding, based on small, selected-population studies of vascular or blood-pressure markers.
Evidence strength
CoQ10 leads the evidence finding, based on small, selected-population studies of vascular or blood-pressure markers.
Studied preparation
The counted declarations meet the saved preparation comparison, without establishing finished-product equivalence or superiority of a particular delivery form.

Formulation logic100

No required partner is missing and none of the listed stimulant or high-sodium conditions applies. Counted ingredients meet the minimum amount comparison.
Partner coverage
No counted ingredient lacks a required partner under the supplied findings; this does not establish extra benefit from combining them.
Conflicts
The listed caffeine, stimulant and high-sodium conditions are not triggered by the supplied facts; this is a limited conflict check.
Effective doses
All counted ingredients meet the saved minimum amount comparison; excluded preparations and smaller contributions are not made effective by this finding.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports cellular energy production and antioxidant defence. Its relevance to visible skin aging rests on limited preparation-specific findings for wrinkles and smoothness, with only partial dose support in the saved assessment.

How this product is rated for Longevity

Ingredient fit73

The relevant ingredients give a focused contribution to this goal. The saved findings show partial dose support overall; smaller or unresolved amounts limit the contribution.
Goal fit
The relevant ingredients give a focused contribution to this goal.
Dose adequacy
The saved findings show partial dose support overall; smaller or unresolved amounts limit the contribution.

Pathways10

The strongest saved contribution relates to mitochondrial energy production, with limited coverage. None of the reviewed pathways reaches the saved coverage threshold.
Depth
The strongest saved contribution relates to mitochondrial energy production, with limited coverage.
Breadth
None of the reviewed pathways reaches the saved coverage threshold.

Evidence30

Coenzyme Q-10 provides the strongest effective ingredient evidence in the saved assessment; this concerns bounded outcomes rather than lifespan. The effective ingredient is not identified as the preparation used in the reviewed trials.
Evidence strength
Coenzyme Q-10 provides the strongest effective ingredient evidence in the saved assessment; this concerns bounded outcomes rather than lifespan.
Studied preparation
The effective ingredient is not identified as the preparation used in the reviewed trials.

Formulation logic100

The reviewed contributors can work independently or have their required partner in the supplied facts. No matched ingredient conflict was recorded in the saved assessment.
Partner coverage
The reviewed contributors can work independently or have their required partner in the supplied facts.
Conflicts
No matched ingredient conflict was recorded in the saved assessment.
Effective doses
1 of 1 assessed ingredients meet the saved minimum dose threshold.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 may support selected blood-vessel function, blood-pressure or lipid markers. The supplied studies involved adults with abnormal lipids, including a small ubiquinol study in people with impaired vessel function, so broader benefits remain uncertain. These marker findings do not establish prevention of cardiovascular events or superiority of one CoQ10 form.

How this product is rated for Cardiovascular Support

Ingredient fit86

CoQ10 is a relevant active, with a partial saved amount finding.
Goal fit
The relevant active ingredients are central to the formula, though it is linked to several goals.
Dose adequacy
The saved amount finding is partial; lower or unresolved amounts limit the contribution attributed to this serving.

Pathways53

The saved findings are strongest for endothelial nitric-oxide function.
Depth
The strongest saved contribution concerns endothelial nitric-oxide function. This describes a selected mechanism rather than demonstrated event prevention.
Breadth
The saved coverage findings concern endothelial nitric-oxide function.

Evidence88

CoQ10 evidence supports selected markers in studied populations.
Evidence strength
Coenzyme Q-10 leads the saved evidence finding; the supplied evidence concerns selected markers or nutrient roles rather than broad event prevention.
Studied preparation
The included preparations meet the saved preparation finding; this does not imply identical effects across populations or superior forms.

Formulation logic100

Partner requirements are satisfied and no matched conflicts were recorded; minimum amount findings vary by ingredient.
Partner coverage
No unmet partner requirement was recorded for the included ingredients; this does not establish extra benefit from combining them.
Conflicts
No matched formulation conflict was recorded in the supplied assessment.
Effective doses
The included ingredients meet the saved minimum amount criterion; it is not a proven effective clinical dose.
Study evidence
Energy
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg relates to mitochondrial energy production, with partial dose support. Fatigue findings depend on the preparation, and the generic CoQ10 declaration leaves uncertainty about how closely those findings apply.

How this product is rated for Energy

Ingredient fit73

The assessed ingredient is closely focused on energy, although it also has other uses. The assessed amounts provide partial dose support.
Goal fit
The assessed ingredient is closely focused on energy, although it also has other uses.
Dose adequacy
The assessed amounts provide partial dose support.

Pathways8

The strongest assessed connection is mitochondrial energy production, with limited coverage. No assessed pathway reaches the saved threshold for substantial coverage.
Depth
The strongest assessed connection is mitochondrial energy production, with limited coverage.
Breadth
No assessed pathway reaches the saved threshold for substantial coverage.

Evidence27

Coenzyme Q-10 supplies the strongest effective-dose evidence in the saved findings, within the ingredient’s stated limits. The assessed preparation is not matched to the reviewed trials in the saved findings.
Evidence strength
Coenzyme Q-10 supplies the strongest effective-dose evidence in the saved findings, within the ingredient’s stated limits.
Studied preparation
The assessed preparation is not matched to the reviewed trials in the saved findings.

Formulation logic100

The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 participates in cellular energy handling and antioxidant processes. A small trial of ubiquinone in statin-treated coronary artery disease found a change in one inflammatory marker, while others were unchanged; this does not establish routine clinical benefit. The 100 mg selected serving is below the 300 mg daily exposure used in that trial.

How this product is rated for Inflammation

Ingredient fit66

The relevant active is concentrated in this product, although its uses extend beyond inflammation. The selected serving receives partial amount recognition relative to the saved comparison, without establishing a clinical dose.
Goal fit
The relevant active is concentrated in this product, although its uses extend beyond inflammation.
Dose adequacy
The selected serving receives partial amount recognition relative to the saved comparison, without establishing a clinical dose.

Pathways13

The main assigned contribution concerns oxidative and mitochondrial stress; this classification does not prove a clinical anti-inflammatory effect. No specified mechanism reached the coverage requirement.
Depth
The main assigned contribution concerns oxidative and mitochondrial stress; this classification does not prove a clinical anti-inflammatory effect.
Breadth
No specified mechanism reached the saved coverage requirement.

Evidence93

Coenzyme Q-10 leads the saved comparison. Recognized amounts and preparations do not resolve the clinical and biomarker limitations.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison, while the supplied population and biomarker limitations constrain expected benefit.
Studied preparation
The saved comparison recognizes the qualifying preparation; this does not establish that the full product reproduces a clinical trial regimen.

Formulation logic100

The included contributions meet the saved amount requirement, with no missing required partner or identified ingredient conflict.
Partner coverage
No required partner was missing among the included contributions; this does not establish added benefit from combining ingredients.
Conflicts
No ingredient conflict was identified by the supplied checks.
Effective doses
All included contributions met the saved minimum amount requirement, which is not proof of a clinically effective dose.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q-10 participates in mitochondrial energy production, but that normal role does not establish a rise in whole-body energy expenditure. The supplied metabolic-marker studies concern different outcomes and do not establish routine thermogenesis or durable weight loss. The 100 mg per serving receives a partial amount allowance in the saved comparison, rather than establishing an effective thermogenic dose.

How this product is rated for Metabolism Support

Ingredient fit73

The ingredients receive recognition for their connection and amounts in the saved findings. Normal nutrient functions and comparison amounts do not establish a metabolic-rate increase.
Goal fit
The recognised ingredient has a focused connection to the goal in the saved finding, although it is linked to other goals too.
Dose adequacy
The counted ingredients provide partial reference amounts overall; those comparisons do not establish proven thermogenic doses.

Pathways17

The recorded connection centres on mitochondrial energy and fat oxidation, without establishing a measured rise in whole-body energy expenditure.
Depth
The recorded connection centres on mitochondrial energy and fat oxidation, without establishing a measured rise in whole-body energy expenditure.
Breadth
None of the evaluated routes has substantial recorded coverage, so broad support for increased energy expenditure is absent.

Evidence75

Coenzyme Q-10 leads the recorded evidence finding, but its normal metabolic role or other study outcomes do not establish thermogenesis.
Evidence strength
Coenzyme Q-10 leads the recorded evidence finding, but its normal metabolic role or other study outcomes do not establish thermogenesis.
Studied preparation
The counted ingredients receive preparation recognition in the saved finding, without establishing a direct energy-expenditure effect.

Formulation logic100

The counted ingredients have no missing required partners or identified conflicts among those evaluated. Their amounts meet the minimum comparison.
Partner coverage
No required ingredient partner is missing for the counted ingredients.
Conflicts
None of the evaluated conflicts was identified; the finding does not cover every possible interaction.
Effective doses
All counted ingredients meet the minimum amount comparison; that does not establish a proven thermogenic dose.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q-10
100 mg 46
Adults 18–50
Report overview
Coenzyme Q-10 · 100 mg OverallScore46
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyC Value
A serving provides 100 mg of CoQ10, but the saved facts do not identify its form. That makes a form-specific absorption comparison difficult.
How this ingredient is rated

Active Ingredient Quality & Bioavailability12

The CoQ10 form is not identified in the saved facts.
Molecular Form: Ubiquinol vs. Ubiquinone
The saved facts do not identify whether the CoQ10 is ubiquinol or ubiquinone, so form-specific absorption cannot be compared.
Formulation & Absorption Enhancers
The saved facts do not identify a liposomal or similar delivery claim or a listed black pepper extract absorption enhancer.

Dose, Safety & Label Transparency72

A serving lists 100 mg of CoQ10.
Clinical Dosage Alignment
A serving lists 100 mg of CoQ10.
Label Transparency & Fillers
The serving lists 100 mg CoQ10, and the available ingredient data do not flag the additives or fillers checked in the evaluation.

Value60

The whole product costs about $0.24 per serving, a moderate price in this comparison.
Price Per Effective Serving
The whole product costs about $0.24 per serving, a moderate price in this comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10